On May 16th, 2023, the POTENTIAL Consortium signed the Grant Agreement with the European Union (EU), setting an official milestone for the start of the project with all LSPs.

The project is born out of a concrete demand within the pharma supply chain to provide a hi-tech solution to tackle the problem of limited-supply and out-of-stock medicine.

From 2028, it will be mandatory to notify intra-EU B2B transactions. Member states have begun the "race to compliance," and Italian companies will need to follow the regulatory developments of the countries where their business partners are located.

Intesa Hive is an innovative and comprehensive interface for managing B2B documents, designed to facilitate analysis and reporting.